Published in J Bone Miner Metab on January 01, 2005
The role of estrogen receptor-alpha gene TA polymorphism and aromatase gene TTTA polymorphism on peak bone mass attainment in males: is there an additive negative effect of certain allele combinations? J Bone Miner Metab (2009) 0.81
Simvastatin induces estrogen receptor-alpha (ER-alpha) in murine bone marrow stromal cells. J Bone Miner Metab (2008) 0.81
Bone mass pharmacogenetics and ethnic health implications. Clin Cases Miner Bone Metab (2007) 0.76
The genetics of response to estrogen treatment. Clin Cases Miner Bone Metab (2009) 0.75
Involutional osteoporosis. N Engl J Med (1986) 8.20
Pharmacogenomics--drug disposition, drug targets, and side effects. N Engl J Med (2003) 7.23
Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med (1994) 6.59
Therapeutic approaches to bone diseases. Science (2000) 5.60
Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial. JAMA (2003) 4.07
Heritable and life-style determinants of bone mineral density. J Bone Miner Res (1993) 1.78
Insights from the study of animals lacking functional estrogen receptor. Science (1994) 1.72
Nonassociation of estrogen receptor genotypes with bone mineral density and estrogen responsiveness to hormone replacement therapy in Korean postmenopausal women. J Clin Endocrinol Metab (1997) 1.48
Association of bone mineral density with polymorphism of the estrogen receptor gene. J Bone Miner Res (1996) 1.45
Association of estrogen receptor dinucleotide repeat polymorphism with osteoporosis. Biochem Biophys Res Commun (1995) 1.26
Evidence of a linkage disequilibrium between polymorphisms in the human estrogen receptor alpha gene and their relationship to bone mass variation in postmenopausal Italian women. Hum Mol Genet (2000) 1.16
Estrogen receptor alpha gene polymorphisms and endometrial cancer risk. Carcinogenesis (2000) 1.13
Estrogen receptor alpha gene polymorphisms and bone mineral density: haplotype analysis in women from the United Kingdom. J Bone Miner Res (2001) 0.94
Non-responders to hormone replacement therapy for the prevention of postmenopausal bone loss: do they exist? Osteoporos Int (1994) 0.93
Dinucleotide repeat polymorphism in the human estrogen receptor (ESR) gene. Hum Mol Genet (1992) 0.93
The association of androgen- and oestrogen-receptor gene polymorphisms with urolithiasis in men. BJU Int (2001) 0.87
A TA repeat polymorphism in the estrogen receptor gene is associated with osteoporotic fractures but polymorphisms in the first exon and intron are not. J Bone Miner Res (2000) 0.84
Identification of early postmenopausal women with no bone response to HRT: results of a five-year clinical trial. Osteoporos Int (2000) 0.83
Estrogen receptor alpha polymorphism as a genetic marker for bone loss, vertebral fractures and susceptibility to estrogen. Maturitas (2002) 0.82
Relation of the estrogen receptor alpha gene microsatellite polymorphism to bone mineral density and the susceptibility to osteoporosis in postmenopausal Chinese women in Taiwan. Maturitas (2001) 0.75
Fragile X premutations and (TA)n estrogen receptor polymorphism in women with ovarian dysfunction. Am J Med Genet (1999) 0.75
Nutritional risk factors of early development of postpartum prediabetes and diabetes in women with gestational diabetes mellitus. Nutrition (2010) 1.50
Isoflavone metabolites and their in vitro dual functions: they can act as an estrogenic agonist or antagonist depending on the estrogen concentration. J Steroid Biochem Mol Biol (2006) 1.43
Degradable polyethylenimine-alt-poly(ethylene glycol) copolymers as novel gene carriers. J Control Release (2005) 1.19
Negative association between metabolic syndrome and bone mineral density in Koreans, especially in men. Calcif Tissue Int (2010) 1.00
Rate of vertical transmission of human papillomavirus from mothers to infants: relationship between infection rate and mode of delivery. Virol J (2012) 0.90
Co-localization and interaction of organic anion transporter 1 with caveolin-2 in rat kidney. Exp Mol Med (2005) 0.87
The changes in circulating osteoprotegerin after hormone therapy in postmenopausal women and their relationship with oestrogen responsiveness on bone. Clin Endocrinol (Oxf) (2005) 0.86
Protective role of CYP1A1*2A in the development of multiple myeloma. Acta Haematol (2008) 0.85
Highly efficient gene transfer with degradable poly(ester amine) based on poly(ethylene glycol) diacrylate and polyethylenimine in vitro and in vivo. J Gene Med (2008) 0.83
Association of Angiotensin-converting enzyme and angiotensinogen gene polymorphisms with preeclampsia. J Korean Med Sci (2004) 0.83
The Estimation of Breast Cancer Disease-Probability by Difference of Individual Susceptibility. Cancer Res Treat (2003) 0.82
Genetic polymorphism of geranylgeranyl diphosphate synthase (GGSP1) predicts bone density response to bisphosphonate therapy in Korean women. Yonsei Med J (2010) 0.81
GntR-type transcriptional regulator PckR negatively regulates the expression of phosphoenolpyruvate carboxykinase in Corynebacterium glutamicum. J Bacteriol (2012) 0.80
The prevalence of GAD antibodies in Korean women with gestational diabetes mellitus and their clinical characteristics during and after pregnancy. Diabetes Metab Res Rev (2009) 0.80
Association of interleukin 10 haplotype with low bone mineral density in Korean postmenopausal women. J Biochem Mol Biol (2004) 0.79
A common mutation in cholesteryl ester transfer protein gene and plasma HDL cholesterol level before and after hormone replacement therapy in Korean postmenopausal women. Korean J Intern Med (2002) 0.78
Marked individual variation in isoflavone metabolism after a soy challenge can modulate the skeletal effect of isoflavones in premenopausal women. J Korean Med Sci (2009) 0.78
Hypercalcemia induced by ovarian clear cell carcinoma producing all transcriptional variants of parathyroid hormone-related peptide gene during pregnancy. Gynecol Oncol (2006) 0.77
Identification of novel variants in transforming growth factor-beta 1 (TGFB1) gene and association analysis with bone mineral density. Hum Mutat (2003) 0.77
The changes in plasma serotonin levels after hormone therapy and their relationship with estrogen responsiveness on bone in postmenopausal women. J Clin Endocrinol Metab (2012) 0.77
Ovarian follicular development and oocyte quality in anestrous ewes treated with melatonin, a controlled internal drug release (CIDR) device and follicle stimulating hormone. Theriogenology (2005) 0.76
Signal amplification by a self-assembled biosensor system designed on the principle of dockerin-cohesin interactions in a cellulosome complex. Analyst (2014) 0.75
Severe hemolytic disease of the newborn due to anti-Di b treated with phototherapy and intravenous immunoglobulin. Ann Clin Lab Sci (2008) 0.75
Enhancing Fatty Acid Production of Saccharomyces cerevisiae as an Animal Feed Supplement. J Agric Food Chem (2017) 0.75